How should severe asymptomatic bicuspid aortic stenosis be managed?

Management of Severe Asymptomatic Bicuspid Aortic Stenosis

For severe asymptomatic bicuspid aortic stenosis, aortic valve replacement (AVR) is indicated when LVEF falls below 55% (ESC/EACTS) or 60% (ACC/AHA), when very severe stenosis is present (Vmax ≥5 m/s or mean gradient ≥60 mmHg) in low-risk patients, or when exercise testing demonstrates symptoms or hemodynamic abnormalities. 1

Primary Indications for Intervention

Reduced Left Ventricular Function

• Both ESC/EACTS and ACC/AHA guidelines mandate AVR when LVEF is reduced without another identifiable cause 1
• ESC/EACTS threshold: LVEF <55% 1
• ACC/AHA threshold: LVEF <60% documented over three serial echocardiographic examinations 1
• The ACC/AHA serial decline requirement may be more conservative despite the higher threshold, as it reduces inter-rater variability 1

Very Severe Stenosis in Low-Risk Patients

Both guidelines now align on intervention for very severe AS with the following parameters in low-risk asymptomatic patients: 1

• Aortic Vmax ≥5 m/s 1
• Mean gradient ≥60 mmHg 1
• This represents a shift from the previous ≥5.5 m/s threshold and reflects evidence from the RECOVERY trial showing survival benefits of early SAVR 1

Exercise Testing Abnormalities

Exercise stress testing is strongly recommended to unmask symptoms, with intervention indicated for: 1

• Decreased exercise tolerance normalized for age and sex 1
• Fall in systolic blood pressure ≥10 mmHg (ACC/AHA) or >20 mmHg (ESC/EACTS) from baseline to peak exercise 1
• Development of symptoms during exercise testing (Class I recommendation) 1

Additional Adverse Prognostic Features

Consider intervention in low-risk patients with preserved LVEF when the following are present (Class IIa recommendations): 1

• Vmax progression ≥0.3 m/s per year 1
• BNP levels >3 times age- and sex-corrected normal range, confirmed by repeated measurements 1
• Severe valve calcification on cardiac CT combined with rapid Vmax progression 1

The ESC/EACTS also considers (though not official recommendations): 1

• Left ventricular global longitudinal strain abnormalities 1
• Indexed stroke volume reduction 1
• Increased left atrial volume 1

Concomitant Cardiac Surgery

If the patient requires cardiac surgery for another indication (CABG, ascending aorta surgery, or another valve), concomitant AVR is indicated 1

• ACC/AHA: Class I recommendation (LOE B-NR) 1
• ESC/EACTS: Class I for severe AS, Class IIa for moderate AS undergoing CABG or aortic/valve surgery 1
• This approach reduces risks of late intervention and redo procedures 1

Choice Between TAVI and SAVR

Age-Based Algorithm for Bicuspid Aortic Valve

For bicuspid aortic valve stenosis specifically, SAVR is strongly preferred in younger patients: 1, 2

• <65 years: SAVR is the clear choice 1
• 65-75 years: SAVR preferred over TAVI 1
• 75-80 years: Either TAVI or SAVR acceptable 1

• 80 years: TAVI preferred 1

Critical Considerations for TAVI in Bicuspid Valves

TAVI in bicuspid aortic valves presents unique technical challenges: 3, 4

• Higher rates of valve underexpansion and ellipticity compared to tricuspid valves 3
• Self-expandable valves (SE-THV) associated with higher rates of paravalvular regurgitation (moderate-severe), additional valve implantation, and permanent pacemaker implantation (18.6% vs 11.9% with balloon-expandable) 4
• Balloon-expandable valves (BE-THV) associated with higher transvalvular gradients and annulus rupture risk 4
• R-L raphe localization is an independent predictor of permanent pacemaker requirement (OR: 2.51) 5

Surgical Risk Stratification

When surgical risk is elevated (STS-PROM >8%), TAVI becomes the preferred option regardless of age 1

• For intermediate risk, either SAVR or TAVI is acceptable 1
• The Heart Team should evaluate comorbidities, anatomy, and frailty 1

Surveillance Strategy for Conservative Management

When intervention is deferred, intensive surveillance is mandatory due to risk of rapid deterioration: 1

• Minimum 6-month follow-up intervals for severe AS 1
• Serial echocardiography monitoring LVEF, Vmax, gradients, and valve area 6
• Exercise testing for early symptom detection 1
• Serial BNP measurements 1
• NT-pro BNP particularly useful when anatomic severity doesn't match clinical presentation 6

Aortic Imaging Requirements

All bicuspid aortic valve patients require aortic evaluation, as 50% have aortic root involvement: 6

• Cardiac MRI preferred (avoids radiation, provides LV function data) 6
• CT angiography if MRI contraindicated 6
• No aortic dilation: echocardiography alone for follow-up 6
• Mild dilation: aortic imaging every 3-5 years 6
• Aortic diameter >4.0 cm: annual aortic imaging 6
• Concomitant aortic surgery indicated if diameter >4.5 cm at time of valve surgery, or >5.0 cm for isolated aortic surgery 6

Critical Pitfalls to Avoid

• Do not delay intervention in truly asymptomatic patients with LVEF decline, as this represents irreversible myocardial damage 1
• Do not rely solely on patient-reported symptoms—exercise testing is essential as many patients unconsciously reduce activity levels 1
• Do not assume TAVI and SAVR are equivalent in younger bicuspid valve patients—SAVR provides proven long-term durability and lower reintervention risk 2
• Do not ignore the ascending aorta—bicuspid valves frequently have associated aortopathy requiring surgical attention 6
• Do not use TAVI in asymptomatic bicuspid AS outside of clinical trials or Heart Team discussion, as evidence is limited and ESC/EACTS awaits RCT data from EARLY TAVR, EASY-AS, and EVoLVeD trials 1